Zuckerman Investment Group Acquires 72,040 Shares of Henry Schein for $3.38 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Fool
- Share Acquisition: Zuckerman Investment Group disclosed a purchase of 72,040 shares of Henry Schein on November 13, investing approximately $3.38 million, which increased its total holdings to 281,339 shares valued at $18.67 million, reflecting sustained confidence in the company.
- Asset Allocation: This acquisition raised Zuckerman's stake in Henry Schein to 1.73%, indicating a strategic focus on the healthcare distributor despite not being among its top five holdings, particularly in light of the company's robust performance.
- Financial Performance: Henry Schein reported a 5% revenue increase to $3.3 billion in Q3, with adjusted EBITDA reaching $295 million and non-GAAP EPS rising 13% year-over-year to $1.38, showcasing strong growth potential in the healthcare market.
- Future Outlook: Management raised the full-year non-GAAP EPS guidance to a range of $4.88 to $4.96 and projected sales growth of 3% to 4%, indicating a potential operating income improvement of over $200 million in the coming years, which is likely to attract long-term investors' interest.
HSIC
$76.435+Infinity%1D
Analyst Views on HSIC
Wall Street analysts forecast HSIC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is 75.78 USD with a low forecast of 58.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
5 Buy
3 Hold
2 Sell
Moderate Buy
Current: 76.130
Low
58.00
Averages
75.78
High
90.00
Current: 76.130
Low
58.00
Averages
75.78
High
90.00
About HSIC
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
